Pharmaceutical Business review

Par Pharmaceutical’s COO resigns

Par has earlier announced a resizing of its generic business as part of an ongoing strategic assessment of the overall business. Mr Martino will stay on through the transition.

Patrick LePore, chairman, CEO and president of Par, said: “All of us at Par are grateful to Jerry for the many contributions he has made to the company. Jerry led us through a very difficult time during our financial restatement and engineered significant improvement to Par’s systems, operations and business practices. We wish him success in his future endeavors.”